Orlando L Catanzaro

Summary

Publications

  1. doi Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system
    Orlando Catanzaro
    Departamento de Biologia, Universidad Argentina John F Kennedy, Buenos Aires, Argentina
    Peptides 44:100-4. 2013
  2. doi Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954
    Orlando Catanzaro
    Departamento de Biologia, Universidad Argentina John F Kennedy, Buenos Aires, Argentina
    Peptides 34:349-52. 2012
  3. ncbi Diabetes and its effects on dental pulp
    Orlando Catanzaro
    Medical School and School of Dentistry, University del Salvador, Buenos Aires, Argentina
    J Oral Sci 48:195-9. 2006
  4. doi Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice
    Orlando L Catanzaro
    Direccion de Investigaciones Cientificas Bioquimico Odontologicas, Universidad Argentina John F Kennedy, Argentina Escuela de Medicina y Odontología, Universidad del Salvador, Argentina
    Neuropeptides 44:187-9. 2010
  5. ncbi Side effects of cyclosporine-A treatment in rats: gingival overgrowth and early hyperglycemia
    Orlando L Catanzaro
    Department of Biochemistry School of Dentistry, John F Kennedy University, USA
    Acta Odontol Latinoam 23:240-3. 2010
  6. ncbi The development of insulitis and the kallikrein-kinin system
    Adriana Zucollo
    Academic Hospital, Brussels, Belgium
    Int Immunopharmacol 2:1941-7. 2002

Collaborators

  • Adriana Zucollo
  • Irene Villareal
  • Damian Dziubecki
  • Ricardo Rodriguez

Detail Information

Publications6

  1. doi Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system
    Orlando Catanzaro
    Departamento de Biologia, Universidad Argentina John F Kennedy, Buenos Aires, Argentina
    Peptides 44:100-4. 2013
    ..The beneficial role of BKB1-R antagonist R-954 for the treatment of diabetic neuropathy is also suggested...
  2. doi Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954
    Orlando Catanzaro
    Departamento de Biologia, Universidad Argentina John F Kennedy, Buenos Aires, Argentina
    Peptides 34:349-52. 2012
    ..The beneficial role of the BKB(1)-R antagonist R-954 for the treatment of the diabetic retinopathy is also suggested...
  3. ncbi Diabetes and its effects on dental pulp
    Orlando Catanzaro
    Medical School and School of Dentistry, University del Salvador, Buenos Aires, Argentina
    J Oral Sci 48:195-9. 2006
    ..These results suggest that diabetes is a critical factor that has profound effects upon oral tissues, resulting in expression of inflammatory mediators and modifications of structural components of dental pulp...
  4. doi Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice
    Orlando L Catanzaro
    Direccion de Investigaciones Cientificas Bioquimico Odontologicas, Universidad Argentina John F Kennedy, Argentina Escuela de Medicina y Odontología, Universidad del Salvador, Argentina
    Neuropeptides 44:187-9. 2010
    ..p.) significantly potentiated the diabetes-induced hyperglycemia; this effect that was totally reversed by R-954. These results provide further evidence for the implication of BKB1-R in the type 1 diabetes mellitus (insulitis)...
  5. ncbi Side effects of cyclosporine-A treatment in rats: gingival overgrowth and early hyperglycemia
    Orlando L Catanzaro
    Department of Biochemistry School of Dentistry, John F Kennedy University, USA
    Acta Odontol Latinoam 23:240-3. 2010
    ..These findings appear to indicate that the development of significant gingival changes induced by CsA is related to new-onset of diabetes mellitus during the immunosuppressive treatment...
  6. ncbi The development of insulitis and the kallikrein-kinin system
    Adriana Zucollo
    Academic Hospital, Brussels, Belgium
    Int Immunopharmacol 2:1941-7. 2002
    ..These results confirm the presence of early modifications of renal function prior to the clinical detection of diabetic hyperglycemia...